FOCUS AREAS: Epilepsy Research
CONTACT: 312-255-180, email@example.com
PROFILE: Robin Harding is the CEO of Cure. Her professional bio shares:
Robin Harding became CEO of CURE in 2014. As CEO, she is responsible for overseeing all aspects of CURE, including fundraising, research, public outreach, advocacy, organizational development and administration. She works closely with the staff to assure that the organization is well-managed and positioned for growth while maintaining efficient operating ratios and with the board, driving global progress toward a cure for epilepsy.
She brings more than 25 years of progressive, successful leadership experience in the non-profit and corporate sector to CURE. She worked with the national headquarters of the Juvenile Diabetes Research Foundation (JDRF) for eight years culminating in the role of EVP and COO. Prior to that she served as the executive director of the local Illinois-based chapter. Additionally, Ms. Harding worked as a director of development for six years for the Alzheimer’s Association in Chicago.
Most recently, Ms. Harding oversaw her own consulting firm, Behind the Scenes (BTS) Productions, Inc., where she built a strong portfolio of clients across multiple categories including medical research and health awareness. In addition to CURE, clients included Lupus Research Institute (LRI), James Tyree Foundation and American Cochlear Implant (ACI) Alliance.
She holds a Bachelor of Arts degree in liberal arts and sciences from the University of Illinois at Chicago and is also a graduate of Northwestern University Kellogg School of Management's Advanced Executive Program.
You can learn more about her background in the press release, Robin Harding Appointed CEO of CURE.